SETD5 Regulates the OGT-catalyzed O-GlcNAcylation of RNA Polymerase II, Which is Involved in the Stemness of Colorectal Cancer Cells

Overview

Journal Sci Rep

Specialty Science

Date 2023 Nov 14

PMID 37963940

Authors

Hye In Cho

Sora Jo

Min Seong Kim

Han Byeol Kim

Xingzhe Liu

Yanhua Xuan

Jin Won Cho

Yeun Kyu Jang

Affiliations

Soon will be listed here.

Abstract

The dosage-dependent recruitment of RNA polymerase II (Pol II) at the promoters of genes related to neurodevelopment and stem cell maintenance is required for transcription by the fine-tuned expression of SET-domain-containing protein 5 (SETD5). Pol II O-GlcNAcylation by O-GlcNAc transferase (OGT) is critical for preinitiation complex formation and transcription cycling. SETD5 dysregulation has been linked to stem cell-like properties in some cancer types; however, the role of SETD5 in cancer cell stemness has not yet been determined. We here show that aberrant SETD5 overexpression induces stemness in colorectal cancer (CRC) cells. SETD5 overexpression causes the upregulation of PI3K-AKT pathway-related genes and cancer stem cell (CSC) markers such as CD133, Kruppel-like factor 4 (KLF4), and estrogen-related receptor beta (ESRRB), leading to the gain of stem cell-like phenotypes. Our findings also revealed a functional relationship between SETD5, OGT, and Pol II. OGT-catalyzed Pol II glycosylation depends on SETD5, and the SETD5-Pol II interaction weakens in OGT-depleted cells, suggesting a SETD5-OGT-Pol II interdependence. SETD5 deficiency reduces Pol II occupancy at PI3K-AKT pathway-related genes and CD133 promoters, suggesting a role for SETD5-mediated Pol II recruitment in gene regulation. Moreover, the SETD5 depletion nullified the SETD5-induced stemness of CRC cells and Pol II O-GlcNAcylation. These findings support the hypothesis that SETD5 mediates OGT-catalyzed O-GlcNAcylation of RNA Pol II, which is involved in cancer cell stemness gain via CSC marker gene upregulation.

Citing Articles

KIF1A promotes neuroendocrine differentiation in prostate cancer by regulating the OGT-mediated O-GlcNAcylation.

Zhou Q, Yang M, Fu J, Sun X, Wang J, Zhang H Cell Death Dis. 2024; 15(11):796.

PMID: 39505875 PMC: 11542072. DOI: 10.1038/s41419-024-07142-2.

References

Wang W, Wang Y, Wang D, Lin Z, Sun R . Integrin beta-8 (ITGB8) silencing reverses gefitinib resistance of human hepatic cancer HepG2/G cell line. Int J Clin Exp Med. 2015; 8(2):3063-71. PMC: 4402930. View

Xue Y, Lai L, Lian W, Tu X, Zhou J, Dong P . SOX9/FXYD3/Src Axis Is Critical for ER Breast Cancer Stem Cell Function. Mol Cancer Res. 2018; 17(1):238-249. DOI: 10.1158/1541-7786.MCR-18-0610. View

Love D, Ghosh S, Mondoux M, Fukushige T, Wang P, Wilson M . Dynamic O-GlcNAc cycling at promoters of Caenorhabditis elegans genes regulating longevity, stress, and immunity. Proc Natl Acad Sci U S A. 2010; 107(16):7413-8. PMC: 2867743. DOI: 10.1073/pnas.0911857107. View

Nakagawa T, Hattori S, Nobuta R, Kimura R, Nakagawa M, Matsumoto M . The Autism-Related Protein SETD5 Controls Neural Cell Proliferation through Epigenetic Regulation of rDNA Expression. iScience. 2020; 23(4):101030. PMC: 7160574. DOI: 10.1016/j.isci.2020.101030. View

Comer F, Hart G . Reciprocity between O-GlcNAc and O-phosphate on the carboxyl terminal domain of RNA polymerase II. Biochemistry. 2001; 40(26):7845-52. DOI: 10.1021/bi0027480. View

Fujiki R, Chikanishi T, Hashiba W, Ito H, Takada I, Roeder R . GlcNAcylation of a histone methyltransferase in retinoic-acid-induced granulopoiesis. Nature. 2009; 459(7245):455-9. DOI: 10.1038/nature07954. View

Deliu E, Arecco N, Morandell J, Dotter C, Contreras X, Girardot C . Haploinsufficiency of the intellectual disability gene SETD5 disturbs developmental gene expression and cognition. Nat Neurosci. 2018; 21(12):1717-1727. DOI: 10.1038/s41593-018-0266-2. View

Seo H, Kim H, Yoon J, Kweon T, Park Y, Kang J . Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. Cell Death Dis. 2020; 11(9):815. PMC: 7525441. DOI: 10.1038/s41419-020-02999-5. View

Fleming-de-Moraes C, Rocha M, Tessmann J, de Araujo W, Morgado-Diaz J . Crosstalk between PI3K/Akt and Wnt/β-catenin pathways promote colorectal cancer progression regardless of mutational status. Cancer Biol Ther. 2022; 23(1):1-13. PMC: 9367664. DOI: 10.1080/15384047.2022.2108690. View

10.

Ormanns S, Neumann J, Horst D, Kirchner T, Jung A . WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear β-Catenin depend on active PI3K signaling. Oncotarget. 2014; 5(10):2999-3011. PMC: 4102786. DOI: 10.18632/oncotarget.1626. View

11.

Valkenburg K, Graveel C, Zylstra-Diegel C, Zhong Z, Williams B . Wnt/β-catenin Signaling in Normal and Cancer Stem Cells. Cancers (Basel). 2013; 3(2):2050-79. PMC: 3757404. DOI: 10.3390/cancers3022050. View

12.

Yu H, Sun J, Zhao C, Wang H, Liu Y, Xiong J . SET domain containing protein 5 (SETD5) enhances tumor cell invasion and is associated with a poor prognosis in non-small cell lung cancer patients. BMC Cancer. 2019; 19(1):736. PMC: 6659235. DOI: 10.1186/s12885-019-5944-2. View

13.

Essex A, Pineda J, Acharya G, Xin H, Evans J . Replication Study: Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Elife. 2019; 8. PMC: 6584130. DOI: 10.7554/eLife.45426. View

14.

Moore S, Seidman J, Ellegood J, Gao R, Savchenko A, Troutman T . Setd5 haploinsufficiency alters neuronal network connectivity and leads to autistic-like behaviors in mice. Transl Psychiatry. 2019; 9(1):24. PMC: 6336863. DOI: 10.1038/s41398-018-0344-y. View

15.

Yu S, Kim M, Park S, Yoo B, Kim K, Jang Y . SET domain-containing protein 5 is required for expression of primordial germ cell specification-associated genes in murine embryonic stem cells. Cell Biochem Funct. 2017; 35(5):247-253. DOI: 10.1002/cbf.3269. View

16.

KELLY W, Dahmus M, Hart G . RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc. J Biol Chem. 1993; 268(14):10416-24. View

17.

Wu N, Jiang M, Han Y, Liu H, Chu Y, Liu H . O-GlcNAcylation promotes colorectal cancer progression by regulating protein stability and potential catcinogenic function of DDX5. J Cell Mol Med. 2018; 23(2):1354-1362. PMC: 6349181. DOI: 10.1111/jcmm.14038. View

18.

Chen Q, Chen Y, Bian C, Fujiki R, Yu X . TET2 promotes histone O-GlcNAcylation during gene transcription. Nature. 2012; 493(7433):561-4. PMC: 3684361. DOI: 10.1038/nature11742. View

19.

Boulay J, Mild G, Lowy A, Reuter J, Lagrange M, Terracciano L . SMAD7 is a prognostic marker in patients with colorectal cancer. Int J Cancer. 2003; 104(4):446-9. DOI: 10.1002/ijc.10908. View

20.

Mikkelsen T, Ku M, Jaffe D, Issac B, Lieberman E, Giannoukos G . Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature. 2007; 448(7153):553-60. PMC: 2921165. DOI: 10.1038/nature06008. View